°£Æí°áÁ¦, ½Å¿ëÄ«µå û±¸ÇÒÀÎ
ÀÎÅÍÆÄÅ© ·Ôµ¥Ä«µå 5% (26,180¿ø)
(ÃÖ´ëÇÒÀÎ 10¸¸¿ø / Àü¿ù½ÇÀû 40¸¸¿ø)
ºÏÇǴϾð ·Ôµ¥Ä«µå 30% (19,290¿ø)
(ÃÖ´ëÇÒÀÎ 3¸¸¿ø / 3¸¸¿ø ÀÌ»ó °áÁ¦)
NH¼îÇÎ&ÀÎÅÍÆÄÅ©Ä«µå 20% (22,040¿ø)
(ÃÖ´ëÇÒÀÎ 4¸¸¿ø / 2¸¸¿ø ÀÌ»ó °áÁ¦)
Close

º´¸®ÇÐ ¿äÁ¡Á¤¸® & ¹®Á¦Áý(BOARD REVIEW SERIES)

¿øÁ¦ : Pathology, 2nd ed.
¼Òµæ°øÁ¦

2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.

ÆǸÅÁö¼ö 42
?
ÆǸÅÁö¼ö¶õ?
»çÀÌÆ®ÀÇ ÆǸŷ®¿¡ ±â¹ÝÇÏ¿© ÆǸŷ® ÃßÀ̸¦ ¹Ý¿µÇÑ ÀÎÅÍÆÄÅ© µµ¼­¿¡¼­ÀÇ µ¶¸³ÀûÀÎ ÆǸŠÁö¼öÀÔ´Ï´Ù. ÇöÀç °¡Àå Àß Æȸ®´Â »óÇ°¿¡ °¡ÁßÄ¡¸¦ µÎ¾ú±â ¶§¹®¿¡ ½ÇÁ¦ ´©Àû ÆǸŷ®°ú´Â ´Ù¼Ò Â÷ÀÌ°¡ ÀÖÀ» ¼ö ÀÖ½À´Ï´Ù. ÆǸŷ® ¿Ü¿¡µµ ´Ù¾çÇÑ °¡ÁßÄ¡·Î ±¸¼ºµÇ¾î ÃÖ±ÙÀÇ À̽´µµ¼­ È®Àνà À¯¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇØ´ç Áö¼ö´Â ¸ÅÀÏ °»½ÅµË´Ï´Ù.
Close
°øÀ¯Çϱâ
Á¤°¡

29,000¿ø

  • 27,550¿ø (5%ÇÒÀÎ)

ÇÒÀÎÇýÅÃ
Àû¸³ÇýÅÃ
  • S-Point Àû¸³Àº ¸¶ÀÌÆäÀÌÁö¿¡¼­ Á÷Á¢ ±¸¸ÅÈ®Á¤ÇϽŠ°æ¿ì¸¸ Àû¸³ µË´Ï´Ù.
Ãß°¡ÇýÅÃ
¹è¼ÛÁ¤º¸
  • 4/26(±Ý) À̳» ¹ß¼Û ¿¹Á¤  (¼­¿ï½Ã °­³²±¸ »ï¼º·Î 512)
  • ¹«·á¹è¼Û
ÁÖ¹®¼ö·®
°¨¼Ò Áõ°¡
  • À̺¥Æ®/±âȹÀü

  • ¿¬°üµµ¼­

  • »óÇ°±Ç

AD

Ã¥¼Ò°³

ÀÌ Ã¥Àº ÇØ´ç ºÐ¾ß Àü°øÀÚµéÀ» À§ÇÑ ±³Àç °â Àü¹®¼­ÀÌ´Ù.

¸ñÂ÷

1. ¼Õ»ó¿¡ ´ëÇÑ ¼¼Æ÷¹ÝÀÀ Cellular Reaction to Injury ¥°. ȯ°æÀû ½ºÆ®·¹½º¿¡ ´ëÇÑ ÀûÀÀ Adaptation to Environmental Stress ¥±. Àú»ê¼Ò¼º ¼¼Æ÷ ¼Õ»ó Hypoxic Cell Injury ¥². ÀÚÀ¯ ¶óµðÄ® ¼Õ»ó Free Radical Injury ¥³. È­ÇÐÀû ¼¼Æ÷ ¼Õ»ó Chemical Cell Injury ¥´. ±«»ç Necrosis : Ç¥ 1-1 ¥µ. ¼¼Æ÷ ÀÚ¸ê»ç Apoptosis ¥¶. °¡¿ªÀû ¼¼Æ÷ º¯È­¿Í ¼¼Æ÷³» ÃàÀû Reversible Cellular Changes and Accumulation ¥·. ´Ü¹éÁú Á¢Èû ÀÌ»ó¿¡ ÀÇÇÑ Áúº´ Abnormalities of Protein Folding ¿¬½À¹®Á¦ 2. ¿°Áõ Inflammation ¥°. ¼­·Ð Introduction ¥±. ±Þ¼º ¿°Áõ Acute Inflammation ¥². ¸¸¼º ¿°Áõ Chronic Inflammation ¥³. Á¶Á÷ÀÇ º¹±¸ Tissue Repair ¿¬½À¹®Á¦ 3. Ç÷¿ªÇÐÀû ÀÌ»ó Hemodynamic Dysfunction ¥°. ÃâÇ÷ Hemorrhage ¥±. ÃæÇ÷ Hyperemia ¥². °æ»öÁõ Infarction ¥³. Ç÷ÀüÁõ Thrombosis ¥´. »öÀüÁõ Embolism ¥µ. ºÎÁ¾ Edema ¥¶. ¼îÅ© Shock ¿¬½À¹®Á¦ 4. À¯ÀüÀû Áúȯ Genetic Disorders ¥°. ¿°»öü ÀÌ»ó Chromosomal Disorders ¥±. ´ÜÀÏ À¯ÀüÀÚ ÀÌ»óÀÇ À¯Àü¹æ½Ä Mode of Inheritance of Mono ... 1. ¼Õ»ó¿¡ ´ëÇÑ ¼¼Æ÷¹ÝÀÀ Cellular Reaction to Injury ¥°. ȯ°æÀû ½ºÆ®·¹½º¿¡ ´ëÇÑ ÀûÀÀ Adaptation to Environmental Stress ¥±. Àú»ê¼Ò¼º ¼¼Æ÷ ¼Õ»ó Hypoxic Cell Injury ¥². ÀÚÀ¯ ¶óµðÄ® ¼Õ»ó Free Radical Injury ¥³. È­ÇÐÀû ¼¼Æ÷ ¼Õ»ó Chemical Cell Injury ¥´. ±«»ç Necrosis : Ç¥ 1-1 ¥µ. ¼¼Æ÷ ÀÚ¸ê»ç Apoptosis ¥¶. °¡¿ªÀû ¼¼Æ÷ º¯È­¿Í ¼¼Æ÷³» ÃàÀû Reversible Cellular Changes and Accumulation ¥·. ´Ü¹éÁú Á¢Èû ÀÌ»ó¿¡ ÀÇÇÑ Áúº´ Abnormalities of Protein Folding ¿¬½À¹®Á¦ 2. ¿°Áõ Inflammation ¥°. ¼­·Ð Introduction ¥±. ±Þ¼º ¿°Áõ Acute Inflammation ¥². ¸¸¼º ¿°Áõ Chronic Inflammation ¥³. Á¶Á÷ÀÇ º¹±¸ Tissue Repair ¿¬½À¹®Á¦ 3. Ç÷¿ªÇÐÀû ÀÌ»ó Hemodynamic Dysfunction ¥°. ÃâÇ÷ Hemorrhage ¥±. ÃæÇ÷ Hyperemia ¥². °æ»öÁõ Infarction ¥³. Ç÷ÀüÁõ Thrombosis ¥´. »öÀüÁõ Embolism ¥µ. ºÎÁ¾ Edema ¥¶. ¼îÅ© Shock ¿¬½À¹®Á¦ 4. À¯ÀüÀû Áúȯ Genetic Disorders ¥°. ¿°»öü ÀÌ»ó Chromosomal Disorders ¥±. ´ÜÀÏ À¯ÀüÀÚ ÀÌ»óÀÇ À¯Àü¹æ½Ä Mode of Inheritance of Monogenic Disorders ¥². ¸àµ¨À¯ÀüÀ» µû¸£´Â Áúȯ Mendelian Disorders ¥³. ´ÙÀ¯ÀüÀÚ ÀÌ»ó Polygenic Disorders ¥´. ¼ººÐÈ­ ÀÌ»ó Disorders of Sexual Differentiation ¿¬½À¹®Á¦ 5. ¸é¿ª Áúȯ Immune Dysfunction ¥°. ¸é¿ª°è¸¦ ±¸¼ºÇÏ´Â ¼¼Æ÷ Cells of the Immune System ¥±. »çÀÌÅäÄ«ÀÎ Cytokines ¥². º¸Ã¼ Complement System ¥³. »ç¶÷¹éÇ÷±¸Ç׿ø Human Leukocyte Antigen : HLA ¥´. ¸é¿ª ¼Õ»óÀÇ ±âÀü Mechanisms of Immune Injury ¥µ. Àå±âÀ̽ĸ鿪 Transplantation of Immunology ¥¶. ¸é¿ª°áÇÌ Áúȯ Immunodeficiency Diseases ¥·. ÀÚ°¡¸é¿ª Autoimmunity ¥¸. °áÇÕÁ¶Á÷Áúȯ Connective Tissue Diseases ¥¹. ¾Æ¹Ð·ÎÀ̵åÁõ Amyloidosis ¿¬½À¹®Á¦ 6. ½Å»ý¹° Neoplasia ¥°. ¼­·Ð General Characteristics-Neoplasis ¥±. Á¾¾çÀÇ ºÐ·ù ¹× ¸í¸í¹ý Classification and Nomenclature of Tumors ¥². Á¾¾çÀÇ Æ¯Â¡ Properties of Neoplasms ¥³. ¹ß¾ÏÇö»ó°ú ¿øÀÎ Carcinogenesis and Etiology ¥´. ±âŸ DNA°áÇÔÀ¸·Î ÀÎÇÑ Á¾¾ç¼º Áúȯ Other Neoplastic Disorders with Kmpwn DNA Defects ¥µ. µî±Þ°ú º´±â Grading and Staging ¿¬½À¹®Á¦ 7. ȯ°æ º´¸® Environmental Pathology ¥°. ¹°¸®Àû ¼Õ»ó Physical Injury ¥±. È­ÇÐ ¹°Áú ³²¿ë Chemical abuse ¥². È­ÇÐ ¹°Áú¿¡ ÀÇÇÑ ¼Õ»ó Environmental Chemical Injuries ¥³. Ä¡·á¾à¹°ÀÇ À¯ÇØÈ¿°ú Adverse Effects of Therapeutic Drugs ¿¬½À¹®Á¦ 8. ¿µ¾çÁúȯ Nutritional Disorders ¥°. ¿µ¾ç½ÇÁ¶ Malnutrition ¥±. ºñŸ¹Î Vitamins ¥². ºñ¸¸ Obesity ¿¬½À¹®Á¦ 9. Ç÷°ü°è Vascular System ¥°. µ¿¸Æ Áúȯ Arterial Disorders ¥±. Á¤¸Æ Áúȯ Venous Disorders ¥². Ç÷°ü Á¾¾ç Tumors of Blood Vessels ¥³. Ç÷°ü¿° ÁõÈıºµé Vasculitis Syndromes or Vasculitides ¥´. ±â´ÉÀû Ç÷°ü Áúȯ Functional Vascular Disorders ¥µ. °íÇ÷¾Ð Hypertension ¿¬½À¹®Á¦ 10. ½ÉÀå The Heart ¥°. ÇãÇ÷¼º ½ÉÀåÁúȯ Ischemic Heart Disease : IHD ¥±. ·ù¸¶Æ¼½º¿­ Rheumatic Fever ¥². ´Ù¸¥ ÇüÅÂÀÇ ½É³»¸·¿° Other Forms of Endocarditis ¥³. ½ÉÀåÆǸ·Áúȯ Valvular Heart Disease ¥´. ¼±Ãµ¼º ½ÉÀåÁúȯ Congenital Heart Disease ¥µ. ½É±Ù Áúȯ Disease of the Myocardium ¥¶. ½ÉÀ帷 Áúȯ Disease of the Pericardium ¥·. ½ÉÀå Á¾¾ç Tumors of the Heart ¥¸. ¿ïÇ÷½ÉºÎÀü Congestive Heart Failure ¥¹. ½ÉÀåºñ´ë Hypertrophy of the Heart ¿¬½À¹®Á¦ 11. ºóÇ÷ Anemia ¥°. Àü¹ÝÀû °³³ä General Concepts ¥±. ±Þ¼ºÃâÇ÷ÈÄ ºóÇ÷ Acute Post-hemorrhagic Anemia ¥². ö°áÇ̺óÇ÷ Iron Deficiency Anemia ¥³. °Å´ëÀûÇ÷¸ð±¸ºóÇ÷ Megaloblastic Anemias ¥´. ¸¸¼ºÁúȯ¿¡ ÀÇÇÑ ºóÇ÷ Anemia & Chronic Disease ¥µ. Àç»ýºÒ·®ºóÇ÷ Aplastic Anemia ¥¶. °ñ¼öġȯ¼ººóÇ÷ Myelophthisic Anemia ¥·. ¿ëÇ÷ºóÇ÷ Hemolytic Anemias ¿¬½À¹®Á¦ 12. Á¶Ç÷ ¹× ¸²ÇÁ±â°üÀÇ Á¾¾ç ¶Ç´Â Áõ½Ä¼º Áúȯ Neoplastic and Proliferative Disorders of the Hematopoietic and Lymphoid Systems ¥°. ¹éÇ÷º´ Leukemia ¥±. °ñ¼öÁõ½ÄÁúȯ Myeloproliferative Diseases ¥². ºñÁ¾¾ç¼º ¸²ÇÁ°è¼¼Æ÷ ºÐ¿­Áõ½Ä Non-neoplastic Lymphoid Proliferations ¥³. ÇüÁú¼¼Æ÷Áúȯ Plasma Cell Disorders ¥´. ¸²ÇÁ°è Á¾¾ç Lymphoid neoplasms ¿¬½À¹®Á¦ 13. ÃâÇ÷¼º Áúȯ Hemorrhagic Disorders ¥°. ÀÏÂ÷ ÁöÇ÷°úÁ¤ÀÇ ÀÌ»ó Disorders of Primary Hemostasis ¥±. ÀÌÂ÷ ÁöÇ÷°úÁ¤ÀÇ ÀÌ»ó Disorders of Secondary Hemostasis ¥². ÀÏÂ÷ ¹× ÀÌÂ÷ ÁöÇ÷°úÁ¤ÀÇ º¹ÇÕÀû ÀÌ»ó Combined Primary and Secondary Hemostatic Defects ¿¬½À¹®Á¦ 14. È£Èí±â°è Respiratory System ¥°. »ó±âµµ Áúȯ Disorders of the Upper Respiratory Tract ¥±. »ó±âµµ Á¾¾ç Tumors of the Upper Respiratory Tract ¥². ¸¸¼ºÆó¼âÈ£Èí±âÁúȯ Chronic Obstructive Pulmonary Disease : COPD ¥³. Á¦ÇÑÈ£Èí±âÁúȯ Restrictive Pulmonary Disease ¥´. ÆóÇ÷°ü Áúȯ Pulmonary Vascular Disease ¥µ. Æó °¨¿° Pulmonary Infection ¥¶. ±âŸ ÆóÁúȯ Miscellaneous disorders of the lungs ¥·. Æó¾Ï Cancers of the Lung ¿¬½À¹®Á¦ 15. ¼ÒÈ­±â°è Gastrointestinal Tract ¥°. ±¸°­ ¹× ÅÎ Áúȯ Diseases of the Mouth and Jaw ¥±. ħ»ù Áúȯ Diseases of the Salivary Glands ¥². ½Äµµ Áúȯ Diseases of the Esophagus ¥³. À§ Áúȯ Diseases of the Stomoch ¥´. ¼ÒÀåÀÇ Áúȯ Diseases of the Small Intestine ¥µ. ´ëÀå Áúȯ Diseases of the Colon ¥¶. Ãæ¼öÀÇ Áúȯ Diseases of the Appendix ¿¬½À¹®Á¦ 16. °£ ´ã³¶ ¿ÜºÐºñ±â°üÀ¸·ÎÀÇ ÃéÀå Liver Gallbladder Exocrine Pancreas ¥°. °£ Áúȯ Diseases of the Liver ¥±. ´ã³¶ Áúȯ Diseases of the Gallbladder ¥². ¿ÜºÐºñ ÃéÀå Áúȯ Diseases of the Exocrine Pancreas ¿¬½À¹®Á¦ 17. ½ÅÀå ¹× ¿ä·Î°è Kidney and Urinary Tract ¥°. ¼±Ãµ¼º ±âÇü Congenital Anomalies ¥±. »ç±¸Ã¼ Áúȯ Glomerular Disease ¥². ¿ä·Î Æó¼â Urinary Tract Obstruction ¥³. ½ÅÀå ¹× ¿ä·Î°è °¨¿° Infection of the Urinary Tract and Kidney ¥´. ½Å¼¼´¢°ü ¹× °£Áú Áúȯ Tubular and Interstitial Disorders ¥µ. ¹Ì¸¸¼º ½ÅÇÇÁú±«»ç Diffuse Cortical Necrosis ¥¶. ½Å¼®È¸Áõ Nephrocalcinosis ¥·. ¿ä¼®Áõ Urolithiasis ¥¸. ½ÅÀåÀÇ ³¶¼ºº´ Cystic Diseases of the Kidney ¥¹. ½ÅºÎÀü Renal Failure XI. ½ÅÀå¿ÜÀû ¿øÀο¡ ÀÇÇÑ Áú¼ÒÇ÷Áõ Nonrenal Causes of Azotemia XII. ½ÅÀå ¿ä·Î°è ¹æ±¤ÀÇ Á¾¾ç Tumors of the Kidney Urinary Tract Bladder ¿¬½À¹®Á¦ 18. ³²¼º »ý½Ä±â°ü Male Reproductive System ¥°. À½°æÀÇ Áúȯ Diseases of the Penis ¥±. °íȯÀÇ Áúȯ Diseases of the Testis ¥². Àü¸³»ù Áúȯ Diseases of the Prostate ¿¬½À¹®Á¦ 19. ¿©¼º »ý½Ä±â°ü ¹× À¯¹æ Female Reproductive System and Breast ¥°. À½¹®°ú Áú Vulva and Vagina ¥±. Àڱà °æºÎ Uterine Cervix ¥². ÀÚ±Ãü Uterine Corpus ¥³. Àڱðü Fallopian Tubes ¥´. ³­¼Ò Ovary ¥µ. ÀӽŠ¿¬°ü Áúȯ Disorders of Pregnancy ¥¶. À¯¹æ Breast ¿¬½À¹®Á¦ 20. ³»ºÐºñ±â°ü Endocrine System ¥°. ³úÇϼöü Pituitary ¥±. °©»ó»ù Thyroid Gland ¥². ºÎ°©»ó»ù Parathyroid Glands ¥³. ºÎ½Å Adrenal Glands ¥´. ³»ºÐºñ ±â°üÀ¸·Î¼­ÀÇ ÃéÀå Endocrine Pancreas ¥µ. ´Ù¹ß³»ºÐºñÁ¾¾ç ÁõÈıº Multiple Endocrine Neoplasia[MEN] Syndrome ¿¬½À¹®Á¦ 21. ÇǺΠSkin ¥°. ÇǺκ´º¯¿¡ °üÇÑ ¿ë¾î Terminology Relating to Skin Diseases ¥±. ¿°Áõ¼º ¹× ¼öÆ÷¼º º´º¯ Inflammatory and Vesicular Lesions ¥². »ö¼ÒÀÌ»óÁúȯ Disorders of Pigmentation ¥³. ¹ÙÀÌ·¯½ºÁúȯ Disorders of Viral Origin ¥´. ±âŸ ÇǺÎÁúȯ Miscellaneous Skin Disorders ¥µ. ÇǺΠ¾Ï Skin Malignancy ¿¬½À¹®Á¦ 22. ±Ù°ñ°Ý°è Musculoskeletal System ¥°. °ñ°Ý±Ù Áúȯ Diseases of Skeletal Muscle ¥±. »ÀÀÇ Áúȯ Diseases of Bone ¥². °üÀýÀÇ º´º¯ Diseases of Joints ¥³. ¿¬ºÎÁ¶Á÷Á¾¾ç Soft Tissue Tumors ¿¬½À¹®Á¦ 23. ½Å°æ°è Nervous System ¥°. ¼±Ãµ¼º Áúȯ Congenital Disorders ¥±. ³úÇ÷°ü Áúȯ Cerebrovascular Disease ¥². µÎºÎ¿Ü»ó Head Injuries ¥³. °¨¿° Infections ¥´. Å»¼öÃÊÁúȯ Demyelinating Disease ¥µ. ÅðÇ༺ Áúȯ Degenerative Disease ¥¶. ¾È°úÀû Áúȯ Ocular Disorders ¥·. ÁßÃ߽Űæ°èÁ¾¾ç CNS Tumors ¿¬½À¹®Á¦ 24. °Ë»ç °á°úÀÇ Çؼ® Interpretation of Diagnostic Tests ¥°. °Ë»ç °á°ú Laboratory Result ¥±. ¹Î°¨µµ¿Í ƯÀ̵µ Sensitivity and Specificity ¥². ¿¹Ãøµµ Predictive Value ¥³. º¯ÀÌ Variation ¿¬½À¹®Á¦ Á¾ÇÕ¹®Á¦ ÇÑ±Û Ã£¾Æº¸±â ¿µ¹® ã¾Æº¸±â

º»¹®Áß¿¡¼­

¿ªÀÚ¼­¹®

¹ú½á 20³âÀÌ Á¶±Ý Áö³­ ÀÏÀÌ´Ù. ¹Ì±¹ Ķ¸®Æ÷´Ï¾ÆÁÖ¿¡¼­ Àü°øÀÇ °úÁ¤À» ¹â±â À§ÇØ FLEX¿Í VQE(Áö±ÝÀÇ USMLE)¸¦ º¸¾Æ¾ß Çß´Ù. ½ÃÇèÀº ¸î ´Þ ¹Û¿¡ ³²Áö ¾Ê¾Ò°í, ÀÇ°ú´ëÇп¡¼­ 4³â°£ ¹è¿î ºÐ·®À» ªÀº ½Ã°£¿¡ º¼ ¾öµÎµµ ³ªÁö ¾Ê¾Æ ¾ÕÀÌ Ä¯Ä¯ÇÏ´ø Áß È¤½Ã³ª ÇÏ´Â ¸¶À½¿¡ UCSF ÀÇ°ú´ëÇÐ ¼­Á¡¿¡ °¡´Ï ¼­°¡ ÇÑÆí¿¡ Board Exam¿¡ °üÇÑ ¿¬½À¹®Á¦ ½Ã¸®Áî°¡ ¸î ¼¼Æ® ²ÈÇô ÀÖ¾ú´Ù. ±× ¶§ ±× Ã¥µéÀº ³ª¿¡°Õ ±¸¼¼ÁÖ °°Àº Á¸Àç¿´´Ù. ±× ³¯ ³ª´Â ±âÃÊÀÇÇÐ °¢ °ú¸ñ´ç µÎ¼¼ ±Ç¾¿ÀÇ ¿¬½À¹®Á¦ÁýÀ» ²ø¾î¾È°í Àܶà ÈïºÐÇؼ­ ÁýÀ¸·Î °¬´ø ±â¾ïÀÌ ³­´Ù. °¢ ´Ü¿øº°·Î Áß¿äÇÑ ¿äÁ¡ Á¤¸®¿Í ±× ´ç½Ã·Î¼­´Â »õ·Î¿î À¯ÇüÀÇ ¹®Á¦, Á¤´ä°ú ÇÔ²² °£°áÇÏÁö¸¸ Áß¿äÇÑ ´Ü¼­°¡ µÇ´Â Çؼ³Àº FLEX¿Í VQE¸¦ ÇÕ°ÝÇϴµ¥ Å«µµ¿òÀÌ µÇ¾úÀ¸¸ç, ±×ÈÄ ¹Ì±¹¿¡ °¥ ±âȸ°¡ ÀÖÀ»¶§ ¸¶´Ù ¿¬½À¹®Á¦ ½Ã¸®Áî Áß º´¸®Çп¡ °üÇÑ Ã¥µéÀ» »ç°ï Çß´Ù. º» Board Review Series´Â ¿©·¯ ½Ã¸®Áî Áß Æ¯È÷ Áñ°Ü »ç¿ëÇÏ´ø Ã¥À̾ú´Âµ¥ À̹ø¿¡ (ÁÖ)½ÅÈï¸Þµå½ÎÀ̾ð½ºÀÇ µµ¿òÀ¸·Î Board Review Series Áß º´¸®ÇÐ Á¦ 2ÆÇÀ» ¹ø¿ªÇÏ°Ô µÇ¾î¼­ ¸Å¿ì ±â»Ú°Ô»ý°¢ÇÑ´Ù.

ÀúÀÚ ¼­¹®¿¡ ±â¼úµÈ ´ë·Î ÀÌ Ã¥Àº ±³°ú¼­·Î »ç¿ëÇϱ⿡´Â ³Ê¹« °£°áÇÏ°í ³»¿ëÀÌ Áý¾àµÇ¾î ÀÖÀ¸³ª º´¸®ÇÐ °­Á¸¦À̼öÇÑ ÇлýÀ¸·Î¼­´Â ²À ¾Ë¾Æ¾ß ÇÒ ¾ÆÁÖ Áß¿äÇÑ ³»¿ëÀÌ ¼ö·ÏµÇ¾î ÀÖÀ¸¸ç ƯÈ÷ ¿¬½À¹®Á¦¿¡ ÀÖ´Â ¹®Á¦µéÀº º¸¼®°ú°°Àº ¹®Á¦µéÀÌ´Ù. ¹®Á¦¿¡ ´ëÇÑ Çؼ³ºÎºÐÀº º» Ã¥¿¡ ¼ö·ÏµÇ¾î ÀÖ´Â ³»¿ë¿¡¸¸ ÀÇÁ¸ÇÏÁö ¸»°í ±³°ú¼­¸¦ Âü°íÇÏ¿© ¹®Á¦¸¦ ÅëÇÏ¿© Áúº´Çö»óÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱ⠹ٶõ´Ù.

À̹ø ¹ø¿ªÆÇ¿¡ »ç¿ëµÈ ¿ë¾î´Â Àǻ籹°¡°í½Ã¸¦ ÁغñÇÏ´Â ÀÇÇеµ¸¦ À§ÇØ ´ëÇÑÀÇ»çÇùȸ¿¡¼­ Á¦Á¤ÇÑ ¡±ÀÇÇпë¾îÁý Á¦4ÆÇ¡±À» ¹ÙÅÁÀ¸·Î ÇÏ¿´´Ù. ³ª¸§´ë·Î Ãæ½ÇÈ÷ ¹ø¿ªÀ» ÇÏ°íÀÚ ³ë·ÂÇÏ¿´Áö¸¸ ¾ÆÁ÷µµ °³¼±ÇØ¾ß ÇÒ Á¡ÀÌ ¸¹À¸¸ç ÀÌ Ã¥ÀÌ º¸´Ù ¿ÏÀüÇÏ°Ô µÇ±â À§Çؼ­´Â ¹«¾ùº¸´Ùµµ ÀÌ Ã¥À» ÀÌ¿ëÇÏ´Â ºÐµéÀÇ Áö¼ÓÀûÀΠäÂï°ú Ãæ°í°¡ ÇÊ¿äÇÏ¸ç ¿©·¯ºÐÀÇ ¾ÖÁ¤ ¾î¸° °ü½ÉÀ» Áø½ÉÀ¸·Î ºÎŹµå¸°´Ù.

¸¶Áö¸·À¸·Î ÀÌ ¹ø¿ª¼­¸¦ Ãâ°£Çϴµ¥ µµ¿òÀ» ÁֽŠ(ÁÖ)½ÅÈï¸Þµå½ÎÀ̾ð½ºÀÇ »çÀå´Ô°ú Á÷¿øµé²² °¨»çÀÇ ¶æÀ» ÀüÇÑ´Ù.

2004³â 2¿ù
Ȳż÷

ÀúÀÚ¼Ò°³

ARTHUR S. SCHNEIDER ¿Ü [Àú] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

Ȳż÷ [¿ª] ½ÅÀ۾˸² SMS½Åû
»ý³â¿ùÀÏ -

ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.

Àü°øµµ¼­/´ëÇб³Àç ºÐ¾ß¿¡¼­ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥

    ¸®ºä

    0.0 (ÃÑ 0°Ç)

    100ÀÚÆò

    ÀÛ¼º½Ã À¯ÀÇ»çÇ×

    ÆòÁ¡
    0/100ÀÚ
    µî·ÏÇϱâ

    100ÀÚÆò

    0.0
    (ÃÑ 0°Ç)

    ÆǸÅÀÚÁ¤º¸

    • ÀÎÅÍÆÄÅ©µµ¼­¿¡ µî·ÏµÈ ¿ÀǸ¶ÄÏ »óÇ°Àº ±× ³»¿ë°ú Ã¥ÀÓÀÌ ¸ðµÎ ÆǸÅÀÚ¿¡°Ô ÀÖÀ¸¸ç, ÀÎÅÍÆÄÅ©µµ¼­´Â ÇØ´ç »óÇ°°ú ³»¿ë¿¡ ´ëÇØ Ã¥ÀÓÁöÁö ¾Ê½À´Ï´Ù.

    »óÈ£

    (ÁÖ)±³º¸¹®°í

    ´ëÇ¥ÀÚ¸í

    ¾Èº´Çö

    »ç¾÷ÀÚµî·Ï¹øÈ£

    102-81-11670

    ¿¬¶ôó

    1544-1900

    ÀüÀÚ¿ìÆíÁÖ¼Ò

    callcenter@kyobobook.co.kr

    Åë½ÅÆǸž÷½Å°í¹øÈ£

    01-0653

    ¿µ¾÷¼ÒÀçÁö

    ¼­¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù)

    ±³È¯/ȯºÒ

    ¹ÝÇ°/±³È¯ ¹æ¹ý

    ¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼­ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼­ ½Åû °¡´É

    ¹ÝÇ°/±³È¯°¡´É ±â°£

    º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É
    ´Ü, »óÇ°ÀÇ °áÇÔ ¹× °è¾à³»¿ë°ú ´Ù¸¦ °æ¿ì ¹®Á¦Á¡ ¹ß°ß ÈÄ 30ÀÏ À̳»

    ¹ÝÇ°/±³È¯ ºñ¿ë

    º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã
    »óÇ°À̳ª ¼­ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯/¹ÝÇ°Àº ¹Ý¼Û·á ÆǸÅÀÚ ºÎ´ã

    ¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯

    ·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
    (´ÜÁö È®ÀÎÀ» À§ÇÑ Æ÷Àå ÈѼÕÀº Á¦¿Ü)

    ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì
    ¿¹) È­ÀåÇ°, ½ÄÇ°, °¡ÀüÁ¦Ç°(¾Ç¼¼¼­¸® Æ÷ÇÔ) µî

    ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì
    ¿¹) À½¹Ý/DVD/ºñµð¿À, ¼ÒÇÁÆ®¿þ¾î, ¸¸È­Ã¥, ÀâÁö, ¿µ»ó È­º¸Áý

    ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì

    ·ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì

    »óÇ° Ç°Àý

    °ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½

    ¼ÒºñÀÚ ÇÇÇغ¸»ó
    ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó

    ·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© 󸮵Ê

    ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼­ÀÇ ¼ÒºñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ

    (ÁÖ)KGÀ̴Ͻýº ±¸¸Å¾ÈÀü¼­ºñ½º¼­ºñ½º °¡ÀÔ»ç½Ç È®ÀÎ

    (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
    (ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼­ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.

    ¹è¼Û¾È³»

    • ±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.

    • Ãâ°í°¡´É ½Ã°£ÀÌ ¼­·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.

    • ±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.

    • ¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.

    • - µµ¼­ ±¸¸Å ½Ã 15,000¿ø ÀÌ»ó ¹«·á¹è¼Û, 15,000¿ø ¹Ì¸¸ 2,500¿ø - »óÇ°º° ¹è¼Ûºñ°¡ ÀÖ´Â °æ¿ì, »óÇ°º° ¹è¼Ûºñ Á¤Ã¥ Àû¿ë